Medtronic (NYSE:MDT) CEO Geoff Martha has no intention of slowing the medtech giant down amid the COVID-19 pandemic. Speaking during the Fridley, Minn.-based company’s “Investor Day” virtual presentation, Martha made one thing clear: “We are going on the offensive,” Martha said at the start and echoed throughout the program. About six months into his tenure as […]
Cardiovascular
Medtronic launches head-to-head TAVR study against Edwards
Medtronic (NYSE:MDT) today announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS), primarily in women. The postmarket SMART trial will compare valve safety and performance of the self-expanding Medtronic Evolut PRO and PRO+TAVR Systems against Edwards Lifesciences’ (NYSE:EW) balloon-expandable SAPIEN 3 and […]
FDA clears GE Healthcare AI-powered cardiovascular ultrasound system
GE Healthcare (NYSE:GE) announced that it received FDA 510(k) clearance for its Ultra Edition package on Vivid cardivascular ultrasound systems. The Ultra Edition package on Vivid cardiovascular ultrasound systems includes new features that are based on artificial intelligence (AI) designed to enable clinicians to acquire faster, more repeatable exams on a consistent basis, according to a […]
SpectraWave names new CEO
Coronary artery disease (CAD) treatment startup SpectraWave announced today that it has appointed Eman Namati as its new CEO. Bedford, Mass.-based SpectraWave is developing a medical imaging platform that uses photonics to improve CAD outcomes. Namati joins with more than a decade of experience leading the development and launch of highly technical medical imaging products, […]
Fresenius to enter heart, lung, organ failure markets
Fresenius Medical Care (NYSE:FMS) announced today that its new growth strategy includes treating heart, lung and multi-organ failure. Hamburg, Germany-based Fresenius’ strategy centers around three major areas: renal care, critical care solutions and complementary assets, according to a news release. The company’s renal care continuum is to be bolstered by artificial intelligence and data analysis technologies […]
AI could boost Edwards’ critical care business
Critical care comprises nearly 20% of Edwards’ revenue. Its continued growth is connected to the prominence of the company’s heart valve business. Katie Szyman spent 23 years at Medtronic, a giant in the Medtech industry, but a patient-focused outlook became a driving force behind a change for her. Wanting to work for a California-based company […]
J&J wins FDA approval for ablation catheter
Johnson & Johnson (NYSE:JNJ) recently announced that its Biosense Webster business has secured FDA approval for its Thermocool SmartTouch SF ablation catheter. The Thermocool SmartTouch received approval for the treatment of persistent atrial fibrillation, J&J announced yesterday. Get the full story on our sister site Medical Tubing + Extrusion.
The top 10 medical disruptors of 2021
For the past 18 years, the Cleveland Clinic has predicted what the top 10 medical disruptors will be for the following year. The list of technologies, cultivated by a panel of physicians and scientists at the clinic, was led by Dr. Will Morris, executive medical director of Cleveland Clinic Innovations, and Dr. Akhil Saklecha, managing […]
JenaValve appoints new chief commercial officer
JenaValve Technology has appointed Peter L. Spadaro Jr. to the newly created position of chief commercial 0fficer. Spadaro is an experienced cardiovascular sales and marketing executive who has held senior positions at industry giants including Medtronic, St. Jude Medical and most recently Syncardia. “Peter’s proven success in all aspects of launching and commercializing innovative structural […]
Boston Scientific launches aortic valve system in Europe
Boston Scientific (NYSE:BSX) announced today that it began a controlled launch of its Acurate neo2 aortic valve system in Europe. Marlborough, Mass.-based Boston Scientific’s next-generation transcatheter aortic valve implantation (TAVI) technology is designed to improve upon the original version of the Acurate neo platform. Acurate neo2 has expanded indication for patients with aortic stenosis (with no […]
The top 5 MassDevice stories of the week — September 25, 2020
The past week in medtech saw Boston Scientific (NYSE:BSX) make an interesting move in the Afib space — and much more. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top […]
